Analysts’ Viewpoint on Prefilled Syringes Market Scenario
The market for prefilled syringes is growing due to the expansion of home care services, increase in usage of injectable medications, surge in prevalence of chronic diseases, and advantages of prefilled syringes over conventional vials. Furthermore, technology developments related to prefilled syringes are boosting the market. However, availability of alternate medicine delivery techniques, stringent government regulations, and product recalls are anticipated to restrain the global market. On the other hand, development of biologics and biosimilars; and rise in demand for injectable medications in prefilled forms present lucrative opportunities for companies operating in the global prefilled syringes market.
Prefilled syringe is a disposable syringe that already contains the substance to be injected. Prefilled syringe has emerged as one of the most convenient drug delivery methods in the last few years. It is one of the rapidly growing options for unit dose delivery. Plastic disposable syringes have ushered in a revolution in the healthcare industry. Introduction of sterile, prefilled syringes that allow safe self-administration of injectable drugs without the need for hospitalization is driving the prefilled syringes market.
Chronic diseases, such as type 1 diabetes, are becoming more common in large populations around the world. Patients with type 1 diabetes receive insulin intravenously on a regular basis to control their blood sugar levels. Prefilled syringes can make self-administration more convenient and viable due to their ease of usage. According to the International Diabetes Federation, approximately 537 million adults (20-79 years) had diabetes in December 2021, and approximately 6.7 million deaths occurred globally due to diabetes in 2021.
The COVID-19 pandemic has had a positive impact on the global prefilled syringes market. In September 2021, BD, a U.S.-based multinational medical technology company, demonstrated the suitability of its glass prefilled syringes for use with mRNA COVID-19 vaccine shots that require ultralow temperature storage. According to the company, switching from vials to prefilled syringes can reduce the complexity and cost of vaccine administration.
Rise in incidence and prevalence of chronic and lifestyle diseases worldwide is a major driver of the prefilled syringes market. Furthermore, demand for self-injection devices, such as saline syringes, is increasing owing to the convenience and safety associated with their usage. Diabetes affected 436 million individuals worldwide in 2019 (prevalence 9.3%). By 2045, the number is projected to climb to 700 million (prevalence 10.9%). Additionally, more than 1.1 million children and teenagers have type 1 diabetes (Source: International Diabetes Federation).
Insulin-dependent diabetics are increasingly turning to dependable and risk-free methods of self-injection such as prefilled insulin syringes. For instance, NovoLog FlexPen prefilled syringe is a fast acting insulin that is used to improve blood sugar control in adults and children with diabetes mellitus. Integration of autoinjectors and pen injectors with prefilled syringes is one of the major factors influencing the need for self-administrable devices.. Thus, preference for self-administration is anticipated to boost the prefilled syringes market size in the next few years.
Introduction of needlestick safety-equipped devices, advanced lubrication technology, and the type of multi-chamber syringes are all major technological developments in the syringe industry. Widespread usage of prefilled syringes has enabled pharmaceutical companies to reduce drug waste, while also increasing product lifespan. Prefilled syringes are regarded as the best method for storing medications, as they promote self-administration, reduce overfill waste, and mitigate the risk of misuse. This benefits patients, healthcare practitioners, and manufacturers in equal measure.
In terms of type, the safety syringes segment is projected to dominate the global market with 77% share by 2031. Safety syringes have removable or permanently connected needles as well as an internal safety device. Several countries have passed laws mandating the usage of safety syringes. Safety syringes are being used in order to reduce needlestick injuries. Several hospitals, diagnostic centers, and general practitioners employ safety prefilled syringes for drug delivery, as these offer less overfills and better safety to patients.
Prefilled syringes are available in various designs. These include single chamber prefilled syringes, dual chamber prefilled syringes, and multiple chamber prefilled syringes. Based on design, the single chamber segment dominated the global market with around 70% share in 2021. Single-chamber prefilled syringes are used for injecting prefilled vaccine products and biological or pharmaceutical products. They are available at various sales channels such as hospital pharmacies, retail pharmacies, and online pharmacies. Major companies offering single-chamber prefilled syringes are focusing on developing technological solutions for the single-chamber prefilled syringe market. For instance, in 2019, Biocorp, a medical device manufacturing company based in France, released Injay, a single-chamber prefilled syringe that uses a Near Field Communication (NFC) chip to store information such as drug name, batch number, and expiration date, and transfers this data when scanned with the provided code. This information is transmitted to the doctor from the patient's phone at the specified date and time when the patient injected the drug. Such developments are expected to propel the segment in the next few years.
Demand for dual chamber prefilled syringes is also increasing at a steady pace across the globe. This is estimated to augment the dual chamber prefilled syringes market during the forecast period.
In terms of material, the glass segment led the global prefilled syringes market with around 60% share in 2021. Demand for glass-based prefilled syringes is expected to rise in the next few years, owing to significant advantages of these syringes. Glass prefilled syringes offer high stability, prevention of drug interaction with oxygen or water vapor, and high compatibility. Furthermore, glass prefilled syringes are more heat resistant.
In terms of distribution channel, the hospital pharmacies segment is projected to dominate the global market with 50% share by 2031. Hospitals are key consumers of prefilled syringes. Hospital pharmacies have remained the most popular and convenient location for vaccinations and cancer treatments. Increase in number of diseases and surge in geriatric population across the globe are anticipated to drive the hospital pharmacies segment in the near future.
North America dominated the global prefilled syringes market in 2021. The market in the region is anticipated to grow at a CAGR of 6.8% from 2022 to 2031 due to the increase in research and development activities in research labs and pharmaceutical companies; and government initiatives for various vaccination programs. Furthermore, the prefilled syringes market in North America is expected to be driven by the increase in adoption of safety prefilled syringes and emphasis on needlestick injury prevention.
The market in Asia Pacific is growing at a rapid pace owing to the increase in rate of diabetes, infectious diseases, and cancer. This is driving the demand for specific treatments, which in turn is augmenting the demand for prefilled syringes. Furthermore, technological advancements and product launches in Asia Pacific, particularly in Japan (Daikyo-Crystal Zenith) and China; and improved reimbursement policies are propelling the prefilled syringes market in Asia Pacific. The Government of China’s health care reforms, favorable regulatory environment, increase in pharmaceutical development, aging population, healthcare innovations, and presence of the highest number of diabetic patients in the country are also propelling the market in the region.
The global prefilled syringes market report concludes with the company profiles section, which includes information about key players in the global prefilled syringes market. Leading players analyzed in the report are B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company (BD), Catalent, Inc., Elcam Medical, Gerresheimer AG, Nipro Corporation, SCHOTT AG, Terumo Corporation, Vetter Pharma, Weigao Group, and West Pharmaceutical Services, Inc.
Each of these players has been profiled in the prefilled syringes market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Market Size Value in 2021 |
US$ 13.6 Bn |
|
Market Forecast Value in 2031 |
More than US$ 35.7 Bn |
|
Growth Rate (CAGR) |
10.1% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global prefilled syringes market was valued at US$ 13.6 Bn in 2021.
The global prefilled syringes market is projected to exceed US$ 35.7 Bn by 2031.
The global prefilled syringes market is anticipated to grow at a CAGR of 10.1% from 2022 to 2031.
New product launches and rise in awareness about the benefits of prefilled syringes are the prominent trends in the global market.
The chronic disease treatment segment held over 59% share of the global prefilled syringes market in 2021.
North America is expected to account for major share of the global prefilled syringes market during the forecast period.
B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company (BD), Catalent, Inc., Elcam Medical, Gerresheimer AG, Nipro Corporation, SCHOTT AG, Terumo Corporation, Vetter Pharma, Weigao Group, and West Pharmaceutical Services, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Venous Diseases Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Technological Advancements
5.3. Pipeline Analysis
5.4. Key Mergers & Acquisitions
5.5. Disease Prevalence & Incidence Rate globally with key countries
5.6. Reimbursement Scenario by Region/globally
6. Global Prefilled Syringes Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Safety Syringes
6.3.2. Conventional Syringes
6.4. Market Attractiveness by Type
7. Global Prefilled Syringes Market Analysis and Forecast, by Design
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Design, 2017-2031
7.3.1. Single Chambers
7.3.2. Dual Chamber
7.3.3. Multiple Chamber
7.4. Market Attractiveness by Design
8. Global Prefilled Syringes Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Material, 2017-2031
8.3.1. Glass
8.3.2. Plastic
8.4. Market Attractiveness by Material
9. Global Prefilled Syringes Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Application, 2017-2031
9.3.1. Chronic Disease Treatment Syringes
9.3.2. Vaccine Syringes
9.3.3. Anticoagulant Syringes
9.3.4. Acute Care and Specialty Syringes
9.3.5. Others
9.4. Market Attractiveness by Application
10. Global Prefilled Syringes Market Analysis and Forecast, by Distribution Channel
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies & Drug Stores
10.3.3. E-commerce
10.4. Market Attractiveness by Distribution Channel
10.2. Key Findings / Developments
10.3. Market Value Forecast, by Distribution Channel, 2017-2031
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies & Drug Stores
10.3.3. E-commerce
10.5. Market Attractiveness by Distribution Channel
11. Global Prefilled Syringes Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness by Country/Sub-region
12. North America Prefilled Syringes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Safety Syringes
12.2.2. Conventional Syringes
12.3. Market Value Forecast, by Design, 2017-2031
12.3.1. Single Chambers
12.3.2. Dual Chamber
12.3.3. Multiple Chamber
12.4. Market Value Forecast, by Material, 2017-2031
12.4.1. Glass
12.4.2. Plastic
12.5. Market Value Forecast, by Application, 2017-2031
12.5.1. Chronic Disease Treatment Syringes
12.5.2. Vaccine Syringes
12.5.3. Anticoagulant Syringes
12.5.4. Acute Care and Specialty Syringes
12.5.5. Others
12.6. Market Value Forecast, by Distribution Channel, 2017-2031
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies & Drug Stores
12.6.3. E-commerce
12.7. Market Value Forecast, by Country, 2017-2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Design
12.8.3. By Material
12.8.4. By Application
12.8.5. By Distribution Channel
12.8.6. By Country
13. Europe Prefilled Syringes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Safety Syringes
13.2.2. Conventional Syringes
13.3. Market Value Forecast, by Design, 2017-2031
13.3.1. Single Chambers
13.3.2. Dual Chamber
13.3.3. Multiple Chamber
13.4. Market Value Forecast, by Material, 2017-2031
13.4.1. Glass
13.4.2. Plastic
13.5. Market Value Forecast, by Application, 2017-2031
13.5.1. Chronic Disease Treatment Syringes
13.5.2. Vaccine Syringes
13.5.3. Anticoagulant Syringes
13.5.4. Acute Care and Specialty Syringes
13.5.5. Others
13.6. Market Value Forecast, by Distribution Channel, 2017-2031
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies & Drug Stores
13.6.3. E-commerce
13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Design
13.8.3. By Material
13.8.4. By Application
13.8.5. By Distribution Channel
13.8.6. By Country/Sub-region
14. Asia Pacific Prefilled Syringes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Safety Syringes
14.2.2. Conventional Syringes
14.3. Market Value Forecast, by Design, 2017-2031
14.3.1. Single Chambers
14.3.2. Dual Chamber
14.3.3. Multiple Chamber
14.4. Market Value Forecast, by Material, 2017-2031
14.4.1. Glass
14.4.2. Plastic
14.5. Market Value Forecast, by Application, 2017-2031
14.5.1. Chronic Disease Treatment Syringes
14.5.2. Vaccine Syringes
14.5.3. Anticoagulant Syringes
14.5.4. Acute Care and Specialty Syringes
14.5.5. Others
14.6. Market Value Forecast, by Distribution Channel, 2017-2031
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies & Drug Stores
14.6.3. E-commerce
14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
14.7.1. Japan
14.7.2. China
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Design
14.8.3. By Material
14.8.4. By Application
14.8.5. By Distribution Channel
14.8.6. By Country/Sub-region
15. Latin America Prefilled Syringes Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2031
15.2.1. Safety Syringes
15.2.2. Conventional Syringes
15.3. Market Value Forecast, by Design, 2017-2031
15.3.1. Single Chambers
15.3.2. Dual Chamber
15.3.3. Multiple Chamber
15.4. Market Value Forecast, by Material, 2017-2031
15.4.1. Glass
15.4.2. Plastic
15.5. Market Value Forecast, by Application, 2017-2031
15.5.1. Chronic Disease Treatment Syringes
15.5.2. Vaccine Syringes
15.5.3. Anticoagulant Syringes
15.5.4. Acute Care and Specialty Syringes
15.5.5. Others
15.6. Market Value Forecast, by Distribution Channel, 2017-2031
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies & Drug Stores
15.6.3. E-commerce
15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Design
15.8.3. By Material
15.8.4. By Application
15.8.5. By Distribution Channel
15.8.6. By Country/Sub-region
16. Middle East & Africa Prefilled Syringes Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017-2031
16.2.1. Safety Syringes
16.2.2. Conventional Syringes
16.3. Market Value Forecast, by Design, 2017-2031
16.3.1. Single Chambers
16.3.2. Dual Chamber
16.3.3. Multiple Chamber
16.4. Market Value Forecast, by Material, 2017-2031
16.4.1. Glass
16.4.2. Plastic
16.5. Market Value Forecast, by Application, 2017-2031
16.5.1. Chronic Disease Treatment Syringes
16.5.2. Vaccine Syringes
16.5.3. Anticoagulant Syringes
16.5.4. Acute Care and Specialty Syringes
16.5.5. Others
16.6. Market Value Forecast, by Distribution Channel, 2017-2031
16.6.1. Hospital Pharmacies
16.6.2. Retail Pharmacies & Drug Stores
16.6.3. E-commerce
16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Design
16.8.3. By Material
16.8.4. By Application
16.8.5. By Distribution Channel
16.8.6. By Country/Sub-region
17. Competitive Landscape
17.1. Market Player - Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company, 2021
17.3. Company Profiles
17.3.1. Zimmer Biomet Holdings, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Company Financials
17.3.1.3. Growth Strategies
17.3.1.4. SWOT Analysis
17.3.2. Medtronic
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Company Financials
17.3.2.3. Growth Strategies
17.3.2.4. SWOT Analysis
17.3.3. AngioDynamics
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Company Financials
17.3.3.3. Growth Strategies
17.3.3.4. SWOT Analysis
17.3.4. Alma Lasers
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Company Financials
17.3.4.3. Growth Strategies
17.3.4.4. SWOT Analysis
17.3.5. Biolitec AG Untere Viaduktgasse
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Company Financials
17.3.5.3. Growth Strategies
17.3.5.4. SWOT Analysis
17.3.6. Becton, Dickinson and Company
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Company Financials
17.3.6.3. Growth Strategies
17.3.6.4. SWOT Analysis
17.3.7. Boston Scientific Corporation
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Company Financials
17.3.7.3. Growth Strategies
17.3.7.4. SWOT Analysis
17.3.8. Abbott Laboratories
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Company Financials
17.3.8.3. Growth Strategies
17.3.8.4. SWOT Analysis
17.3.9. B. Braun Melsungen AG
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Company Financials
17.3.9.3. Growth Strategies
17.3.9.4. SWOT Analysis
17.3.10. Teleflex Incorporated
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Company Financials
17.3.10.3. Growth Strategies
17.3.10.4. SWOT Analysis
17.3.11. Lumenis
17.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.11.2. Company Financials
17.3.11.3. Growth Strategies
17.3.11.4. SWOT Analysis
17.3.12. Philips
17.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.12.2. Company Financials
17.3.12.3. Growth Strategies
17.3.12.4. SWOT Analysis
List of Tables
Table 01: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 02: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 03: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 04: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 05: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 06: Global Prefilled Syringes Market Value (US$ Bn) Forecast, by Region, 2017-2031
Table 07: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 08: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 09: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 10: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 11: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 12: North America Prefilled Syringes Market Value (US$ Bn) Forecast, by Country, 2017-2031
Table 13: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 14: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 15: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 16: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 17: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 18: Europe Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 19: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 20: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 21: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 22: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 23: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 24: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 25: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 26: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 27: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 28: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 29: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 30: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 31: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 32: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Design, 2017-2031
Table 33: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Material, 2017-2031
Table 34: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Application, 2017-2031
Table 35: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 36: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 02: Global Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 03: Global Prefilled Syringes Market Attractiveness Index Analysis, by Type, 2022-2031
Figure 04: Global Prefilled Syringes Market Revenue (US$ Bn), by Safety Syringes, 2017-2031
Figure 05: Global Prefilled Syringes Market Revenue (US$ Bn), by Conventional Syringes, 2017-2031
Figure 06: Global Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 07: Global Prefilled Syringes Market Attractiveness Index Analysis, by Design, 2022-2031
Figure 08: Global Prefilled Syringes Market Revenue (US$ Bn), by Single Chambers, 2017-2031
Figure 09: Global Prefilled Syringes Market Revenue (US$ Bn), by Industry, 2017-2031
Figure 10: Global Prefilled Syringes Market Revenue (US$ Bn), by Multiple Chamber, 2017-2031
Figure 11: Global Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 12: Global Prefilled Syringes Market Attractiveness Index Analysis, by Material, 2022-2031
Figure 13: Global Prefilled Syringes Market Revenue (US$ Bn), by Plastic, 2017-2031
Figure 14: Global Prefilled Syringes Market Revenue (US$ Bn), by Glass, 2017-2031
Figure 15: Global Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 16: Global Prefilled Syringes Market Attractiveness Index Analysis, by Application, 2022-2031
Figure 17: Global Prefilled Syringes Market Revenue (US$ Bn), by Chronic Disease Treatment Syringes, 2017-2031
Figure 18: Global Prefilled Syringes Market Revenue (US$ Bn), by Vaccine Syringes, 2017-2031
Figure 19: Global Prefilled Syringes Market Revenue (US$ Bn), by Anticoagulant Syringes, 2017-2031
Figure 20: Global Prefilled Syringes Market Revenue (US$ Bn), by Acute Care & Specialty Syringes, 2017-2031
Figure 21: Global Prefilled Syringes Market Revenue (US$ Bn), by Others, 2017-2031
Figure 22: Global Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 23: Global Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 24: Global Prefilled Syringes Market Value (US$ Bn), by Hospital Pharmacies, 2017-2031
Figure 25: Global Prefilled Syringes Market Value (US$ Bn), by Retail Pharmacies & Drug Stores, 2017-2031
Figure 26: Global Prefilled Syringes Market Value (US$ Bn), by E-commerce, 2017-2031
Figure 27: Global Prefilled Syringes Market Value Share Analysis, by Region, 2021 and 2031
Figure 28: Global Prefilled Syringes Market Attractiveness Analysis, by Region, 2021-2031
Figure 29: North America Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 30: North America Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 31: North America Prefilled Syringes Market Attractiveness index Analysis, by Type, 2022-2031
Figure 32: North America Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 33: North America Prefilled Syringes Market Attractiveness index Analysis, by Design, 2022-2031
Figure 34: North America Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 35: North America Prefilled Syringes Market Attractiveness index Analysis, by Material, 2022-2031
Figure 36: North America Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 37: North America Prefilled Syringes Market Attractiveness index Analysis, by Application, 2022-2031
Figure 38: North America Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 39: North America Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 40: North America Prefilled Syringes Market Value Share Analysis, by Country, 2021 and 2031
Figure 41: North America Prefilled Syringes Market Attractiveness Analysis, by Country, 2022-2031
Figure 42: Europe Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 43: Europe Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 44: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Type, 2022-2031
Figure 45: Europe Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 46: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Design, 2022-2031
Figure 47: Europe Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 48: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Material, 2022-2031
Figure 49: Europe Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 50: Europe Prefilled Syringes Market Attractiveness Index Analysis, by Application, 2022-2031
Figure 51: Europe Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 52: Europe Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 53: Europe Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 54: Europe Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 55: Asia Pacific Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 56: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 57: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Type, 2022-2031
Figure 58: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 59: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Design, 2022-2031
Figure 60: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 61: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Material, 2022-2031
Figure 62: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 63: Asia Pacific Prefilled Syringes Market Attractiveness index Analysis, by Application, 2022-2031
Figure 64: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 65: Asia Pacific Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 66: Asia Pacific Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 67: Asia Pacific Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 68: Latin America Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 69: Latin America Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 70: Latin America Prefilled Syringes Market Attractiveness Analysis, by Type, 2022-2031
Figure 71: Latin America Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 72: Latin America Prefilled Syringes Market Attractiveness Analysis, by Design, 2022-2031
Figure 73: Latin America Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 74: Latin America Prefilled Syringes Market Attractiveness Analysis, by Material, 2022-2031
Figure 75: Latin America Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 76: Latin America Prefilled Syringes Market Attractiveness Analysis, by Application, 2022-2031
Figure 77: Latin America Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 78: Latin America Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 79: Latin America Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 80: Latin America Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 81: Middle East & Africa Prefilled Syringes Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 82: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Type, 2021 and 2031
Figure 83: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Type, 2022-2031
Figure 84: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Design, 2021 and 2031
Figure 85: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Design, 2022-2031
Figure 86: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Material, 2021 and 2031
Figure 87: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Material, 2022-2031
Figure 88: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Application, 2021 and 2031
Figure 89: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Application, 2022-2031
Figure 90: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Distribution Channel, 2021 and 2031
Figure 91: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Distribution Channel, 2022-2031
Figure 92: Middle East & Africa Prefilled Syringes Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 93: Middle East & Africa Prefilled Syringes Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Prefilled Syringes Market
